BioCeuticals CardioNutrients Forte 60c

Description

CardioNutrients Forte provides a blend of nutrients, including coenzyme Q10 (CoQ10), alpha-lipoic acid, magnesium orotate and selenium, for comprehensive cardiovascular support. These ingredients work to support cellular energy production, antioxidant activity and healthy heart function.

Features:

• Supports healthy cardiovascular function and cellular energy production.
• Provides potent antioxidant activity to protect against cellular damage, particularly of cardiac tissue, and helps regenerate other antioxidants.
• CoQ10 inhibits LDL cholesterol oxidation.
• Alpha-lipoic acid is integral to nitric oxide synthesis in the vascular endothelial cells.
• Magnesium supports healthy heart rhythm, vascular tone and contractility.
• Orotic acid transports magnesium into cardiac tissue and facilitates its binding to magnesium receptor sites.
• Selenium provides antioxidant protection to cardiac tissue.
  

 

Each capsule contains:
Ubidecarenone (coenzyme Q10)	100mg
Magnesium orotate	400mg
equiv. magnesium	25.6mg
Selenomethionine	166mcg
equiv. selenium	67mcg
Alpha-lipoic acid (R,S form)	100mg

 

No added dairy, gluten, shellfish, soy protein, yeast.
 

• If symptoms persist, talk to your health professional.
• This product contains selenium which is toxic at high doses.
• A daily dose of 150mcg for adults of selenium from dietary supplements should not be exceeded.
• Do not take while on warfarin therapy without medical advice.
• Vitamin supplements should not replace a balanced diet.
  
• If you have any pre-existing conditions, are on any medications, always talk to your health professional before use.
• Some products should be ceased at least two weeks before any elective surgery, please confirm with your health professional.
• Always read the label. Use only as directed.

Prescribing Information:

• The active ingredients contained in this formula have not been shown to be contraindicated during pregnancy or lactation.
• Do not take while on warfarin therapy without medical advice. CoQ10 may affect international normalised ratio (INR). However, a recent randomised, double-blind, placebo-controlled, crossover trial indicated that CoQ10 did not significantly influence the clinical effect of warfarin when given at a dose of 100mg daily.
• Due to the slow synthesis of CoQ10-dependent enzymes, a clinical response may not occur until 8 or more weeks of therapy.